Question 1

What is RUCAPARIB used for?

Accepted Answer

RUCAPARIB (brand name Rubraca) is a Other indicated for fallopian tube, fallopian tube, fallopian tube.

Question 2

How does RUCAPARIB work?

Accepted Answer

RUCAPARIB works through the following mechanism: 12.1 Mechanism of Action Rucaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP-1, PARP-2, and PARP-3, which play a role in DNA repair. In vitro studies have shown that rucaparib-induced cytotoxicity may involve inhibition of PARP enzymatic activity and increased formation of PARP-DNA complexes resulting in DNA damage, apoptosis, and cancer cell death. Increased rucaparib-induced cytotoxicity and anti-tumor activity was observed in tumor cell lines with deficiencies in BRCA1/2 and other DNA repair genes. Rucaparib has been shown to decrease tumor growth in mouse xenograft models of human cancer with or without deficiencies in BRCA ..

Question 3

What are the most common side effects of RUCAPARIB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for RUCAPARIB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is RUCAPARIB the same as Rubraca?

Accepted Answer

Rubraca is a brand name for RUCAPARIB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

RUCAPARIB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations